EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact of the COVID-19 pandemic on the incidence of cardiometabolic risk factors among workers: results from the Japan Epidemiology Collaboration on Occupational Health study

Zobida Islam, Shohei Yamamoto, Yosuke Inoue, Toru Honda, Shuichiro Yamamoto, Tohru Nakagawa, Hiroko Okazaki, Hiroshi Ide, Toshiaki Miyamoto, Takeshi Kochi, Takayuki Ogasawara, Makoto Yamamoto und 7 weitere

Journal of Epidemiology and Community Health · 2025

DOI: 10.1136/jech-2024-222703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Epidemiology and Community Health, 2025. Verfasst von Zobida Islam und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan zislam@hosp.ncgm.go.jp. Hauptthemen laut MEDLINE: COVID-19, Cardiometabolic Risk Factors, Metabolic Syndrome, Occupational Health. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCGM Intramural Research Fund, Industrial Health Foundation, Industrial Disease Clinical Research, JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The COVID-19 pandemic and associated restrictions on human activities have greatly changed lifestyles, which might have deteriorated the cardiometabolic profile.

Objective

This study aimed to examine the effect of the COVID-19 pandemic on the incidence of cardiometabolic risk factors among Japanese workers in fiscal years (FY) 2020 and 2021 compared with the prepandemic period.

Method

This study comprised an average of 71 025 employees in Japan who underwent annual health check-ups for at least two successive years from 2015 to 2021. Annual incidence rates from 2016 to 2021 were assessed for obesity, diabetes, hypertension, dyslipidaemia and metabolic syndrome (MetS). The observed incidence rates in 2020 and 2021 were compared with the predicted incidence based on prepandemic trends (2016 to 2019).

Results

Relative to the prepandemic, the incidence of all the outcomes, except for dyslipidaemia, significantly increased in 2020. Between FY 2016 and 2019, the adjusted mean incidence of obesity, diabetes, hypertension, dyslipidaemia and MetS was 5.0%, 1.4%, 5.3%, 17.4% and 7.6%, respectively. In FY 2020, the adjusted incidence (95% CI) of these outcomes increased to 6.02 (5.80 to 6.24), 1.84 (1.73 to 1.96), 6.62 (6.40 to 6.83), 19.31 (18.83 to 19.78) and 8.51 (8.23 to 8.78), which were higher than the predicted incidence of 5.24 (4.99 to 5.49), 1.54 (1.41 to 1.67), 6.02 (5.76 to 6.27), 18.58 (18.00 to 19.16) and 8.05 (7.71 to 8.38) for 2020, respectively. The incidence returned to the prepandemic levels in FY 2021.

Conclusion

Results showed a worsening of the cardiometabolic profile during the initial year of the pandemic, which was reverted in the second year to the levels before the pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cardiometabolic Risk FactorsMetabolic SyndromeOccupational HealthCardiovascular DiseasesHumansJapanMaleFemaleIncidenceMiddle AgedAdultHypertensionDyslipidemiasSARS-CoV-2ObesityDiabetes MellitusPandemicsRisk Factors

Stichwörter der Autor:innen

COVID-19DIABETES MELLITUSHYPERTENSIONOCCUPATIONAL HEALTH

Autor:innen und Institutionen

  • Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan zislam@hosp.ncgm.go.jp.
  • Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Hitachi Health Care Center, Hitachi Ltd, Ibaraki, Japan.
  • Mitsui Chemicals, Inc, Tokyo, Japan.
  • Nippon Steel Corporation, East Nippon Works, Chiba, Japan.
  • Furukawa Electric Co., Ltd, Tokyo, Japan.

Förderung

  • NCGM Intramural Research Fund
  • Industrial Health Foundation, Industrial Disease Clinical Research
  • JSPS KAKENHI

Zitieren

APA

Islam, Z., Yamamoto, S., Inoue, Y., Honda, T., Yamamoto, S., Nakagawa, T., Okazaki, H., Ide, H., Miyamoto, T., Kochi, T., Ogasawara, T., Yamamoto, M., Gonmori, N., Yamamoto, K., Yokoya, T., Konishi, M., Dohi, S., Kabe, I., & Mizoue, T. (2025). Impact of the COVID-19 pandemic on the incidence of cardiometabolic risk factors among workers: results from the Japan Epidemiology Collaboration on Occupational Health study. Journal of Epidemiology and Community Health. https://doi.org/10.1136/jech-2024-222703

Vancouver

Islam Z, Yamamoto S, Inoue Y, Honda T, Yamamoto S, Nakagawa T, et al. Impact of the COVID-19 pandemic on the incidence of cardiometabolic risk factors among workers: results from the Japan Epidemiology Collaboration on Occupational Health study. Journal of Epidemiology and Community Health. 2025. doi:10.1136/jech-2024-222703

BibTeX
@article{Islam2025,
  author = {Islam, Zobida and Yamamoto, Shohei and Inoue, Yosuke and Honda, Toru and Yamamoto, Shuichiro and Nakagawa, Tohru and Okazaki, Hiroko and Ide, Hiroshi and Miyamoto, Toshiaki and Kochi, Takeshi and Ogasawara, Takayuki and Yamamoto, Makoto and Gonmori, Naoki and Yamamoto, Kenya and Yokoya, Toshitaka and Konishi, Maki and Dohi, Seitaro and Kabe, Isamu and Mizoue, Tetsuya},
  title = {Impact of the COVID-19 pandemic on the incidence of cardiometabolic risk factors among workers: results from the Japan Epidemiology Collaboration on Occupational Health study},
  journal = {Journal of Epidemiology and Community Health},
  year = {2025},
  doi = {10.1136/jech-2024-222703}
}
Kostenlos starten →